The Filing Desk

ImmunityBio vs Xencor

ImmunityBio IBRX · Xencor XNCR · Biotechnology

Xencor reported revenue of $126 million in fiscal 2025, about the same as ImmunityBio's $113 million in fiscal 2025. ImmunityBio's revenue grew 668.3% in its latest year, and Xencor's grew 13.7%. ImmunityBio had an operating margin of -226.0%, against -141.3% at Xencor. Free cash flow was −$309 million at ImmunityBio and −$138 million at Xencor.

Side by side

ImmunityBioXencor
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$113M$126M
Revenue growth668.3%13.7%
Revenue growth a year, last 5 years185.2%0.5%
Gross margin99.3%—
Operating margin−226.0%−141.3%
Net margin−310.2%−73.2%
Free cash flow−$309M−$138M
Free cash flow margin−272.6%−110.1%
Return on capital—−19.9%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count31.3%14.1%
Last close$6.02$37.09
P/E at the last close——
Insider trades, last 12 monthssold $8.4 millionsold $7.4 million
Piotroski F-score3 of 93 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ImmunityBioXencor
Operating margin
Percent of revenue
ImmunityBioXencor
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ImmunityBioXencor

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ImmunityBio and Xencor pages.